| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2002;21:906-912
© 2002 Elsevier Science NL
a Department of General Thoracic Surgery, University of Torino, Ospedale San Giovanni Battista, v. Genova 3, 10126, Turin, Italy
b Unit of Thoracic Surgery, University of Eastern Piedmont, Ospedale Maggiore della Carità, Novara, Italy
Received 7 November 2001; received in revised form 22 January 2002; accepted 1 February 2002.
* Corresponding author
e-mail: ottavio.rena{at}tiscalinet.it
Objective: We reviewed our experience in the surgical management of 80 patients with colorectal pulmonary metastases and investigated factors affecting survival. Material and methods: From January 1980 to December 2000, 80 patients, 43 women and 37 men with median age 63 years (range 38–79 years) underwent 98 open surgical procedure (96 muscle-sparing thoracotomy, one clamshell and one median sternotomy) for pulmonary metastases from colorectal cancer (three pneumonectomy, 17 lobectomy, seven lobectomy plus wedge resection, six segmentectomy, three segmentectomy plus wedge resection and 62 wedge resection). Pulmonary metastases were identified at a median interval of 37.5 months (range 0–167) from primary colorectal resection. Second and third resections for recurrent metastases were done in seven and in four patients, respectively. Results: Operative mortality rate was 2%. Overall, 5-year survival was 41.1%. Five-year survival was 43.6% for patients submitted to single metastasectomy and 34% for those submitted to multiple ones. Five-year survival was 55% for patients with disease-free interval (DFI) of 36 months or more, 38% for those with DFI of 0–11 months and 22.6% for those with DFI of 12–35 months (P=0.04). Five-year survival was 58.2% for patients with normal preoperative carcino-embryonic antigen (CEA) levels and 0% for those with pathologic ones (P=0.0001). Patients submitted to second-stage operation for recurrent local disease had 5-year survival rate of 50 vs. 41.1% of those submitted to single resection (P=0.326). Conclusions: Pulmonary resection for metastases from colorectal cancer may help survival in selected patients. Single metastasis, DFI>36 months, normal preoperative CEA levels are important prognostic factors. When feasible, re-operation is a safe procedure with satisfactory long-term results.
Key Words: Pulmonary metastases • Colorectal carcinoma • Lung resection • Carcinoembryonic antigen
This article has been cited by other articles:
|
|
 |
|
  F. Chen, T. Fujinaga, T. Shoji, R. Miyahara, T. Bando, K. Okubo, T. Hirata, and H. Date Pulmonary resection for metastasis from renal cell carcinoma Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 825 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Pass and C. S. Bizekis Surgical Treatment of Sarcomatous Lung Metastases ASCO Educational Book, January 1, 2008; 2008(1): 519 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nakajima, T. Murakawa, T. Fukami, A. Sano, M. Sugiura, and S. Takamoto Is Finger Palpation at Operation Indispensable for Pulmonary Metastasectomy in Colorectal Cancer? Ann. Thorac. Surg., November 1, 2007; 84(5): 1680 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical Resection of Pulmonary Metastases From Colorectal Cancer: A Systematic Review of Published Series Ann. Thorac. Surg., July 1, 2007; 84(1): 324 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Yan, J. King, A. Sjarif, D. Glenn, K. Steinke, A. Al-Kindy, and D. L. Morris Treatment Failure After Percutaneous Radiofrequency Ablation for Nonsurgical Candidates With Pulmonary Metastases From Colorectal Carcinoma Ann. Surg. Oncol., May 1, 2007; 14(5): 1718 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Treasure, M. Utley, and I. Hunt When professional opinion is not enough BMJ, April 21, 2007; 334(7598): 831 - 832. [Full Text] [PDF]
|
|
|
|
|
|
T. D. Yan, J. King, A. Sjarif, D. Glenn, K. Steinke, and D. L. Morris Learning Curve for Percutaneous Radiofrequency Ablation of Pulmonary Metastases From Colorectal Carcinoma: A Prospective Study of 70 Consecutive Cases Ann. Surg. Oncol., December 1, 2006; 13(12): 1588 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Yan, J. King, A. Sjarif, D. Glenn, K. Steinke, and D. L. Morris Percutaneous Radiofrequency Ablation of Pulmonary Metastases from Colorectal Carcinoma: Prognostic Determinants for Survival Ann. Surg. Oncol., November 1, 2006; 13(11): 1529 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yedibela, P. Klein, K. Feuchter, M. Hoffmann, T. Meyer, T. Papadopoulos, J. Gohl, and W. Hohenberger Surgical Management of Pulmonary Metastases from Colorectal Cancer in 153 Patients Ann. Surg. Oncol., November 1, 2006; 13(11): 1538 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Koga, J. Yamamoto, A. Saiura, T. Yamaguchi, E. Hata, and M. Sakamoto Surgical Resection of Pulmonary Metastases From Colorectal Cancer: Four Favourable Prognostic Factors Jpn. J. Clin. Oncol., October 1, 2006; 36(10): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iizasa, M. Suzuki, S. Yoshida, S. Motohashi, K. Yasufuku, A. Iyoda, K. Shibuya, K. Hiroshima, Y. Nakatani, and T. Fujisawa Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann. Thorac. Surg., July 1, 2006; 82(1): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagawa, T. Kamiyama, K. Nakanishi, H. Yokoo, H. Kamachi, M. Matsushita, and S. Todo Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1248 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mae, T. P. O'Connor, and R. G. Crystal Gene Transfer of the Vascular Endothelial Growth Factor Receptor flt-1 Suppresses Pulmonary Metastasis Associated with Lung Growth Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 629 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inoue, M. Ohta, K. Iuchi, A. Matsumura, K. Ideguchi, T. Yasumitsu, K. Nakagawa, K. Fukuhara, H. Maeda, S.-i. Takeda, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma Ann. Thorac. Surg., July 1, 2004; 78(1): 238 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H.V. Reddy, B. Kumar, R. Shah, S. Mirsadraee, K. Papagiannopoulos, P. Lodge, and J. A.C. Thorpe Staged pulmonary and hepatic metastasectomy in colorectal cancer--is it worth it? Eur. J. Cardiothorac. Surg., February 1, 2004; 25(2): 151 - 154. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
